Skip to main content

TWi T086 325 Pill - white capsule/oblong, 21mm

Pill with imprint TWi T086 325 is White, Capsule/Oblong and has been identified as Propafenone Hydrochloride Extended-Release 325 mg. It is supplied by TWi Pharmaceuticals USA, Inc.

Propafenone is used in the treatment of Atrial Fibrillation; Wolff-Parkinson-White Syndrome; Ventricular Tachycardia; Atrial Flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 325 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TWi T086 325

Propafenone Hydrochloride Extended-Release

Imprint
TWi T086 325
Strength
325 mg
Color
White
Size
21.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
TWi Pharmaceuticals USA, Inc.
Manufacturer
TWi Pharmaceuticals, Inc.
National Drug Code (NDC)
24979-0086 (Discontinued)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.